| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Teva Pharmaceutical Industries Ltd (TEVA) has 9 insiders with recent SEC Form 4 filings, including 0 buys and 11 sells. TEVA is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 367.6K | $11.57M | - | |
| VP | 63.6K | $2.00M | - | |
| Other | 52.8K | $1.66M | - | |
| Other | 52.7K | $1.66M | - | |
| VP | 13.0K | $410.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 4, 2019 | Dethlefs Sven | EVP Global Marketing&Portfolio | Sale+OE | 606 | $16.88 | $10,231.28 | -7.0% | |
| Mar 4, 2019 | Daniell Richard | Exec. VP, European Commercial | Sale+OE | 2,098 | $16.88 | $35,423.47 | -100% | |
| Mar 4, 2019 | Nazzi Gianfranco | EVP, Growth Markets Commercial | Sale+OE | 512 | $16.88 | $8,644.81 | -6.1% | |
| Mar 4, 2019 | Griffin Deborah A | Chief Accounting Officer | Sale+OE | 4,107 | $16.88 | $69,339.71 | -77.9% | |
| Feb 14, 2019 | Stark David Matthew53 | Exec. VP Chief Legal Officer | Sale+OE | 3,926 | $17.74 | $69,647.24 | -56.9% | |
| Feb 14, 2019 | Fridriksdottir Hafrun47 | Executive VP, Global R&D | Sale+OE | 1,841 | $17.67 | $32,528.63 | -10.7% | |
| Feb 14, 2019 | De Notaristefani Carlo | Executive VP Global Operations | Sale+OE | 3,192 | $17.67 | $56,399.45 | -14.9% | |
| Feb 13, 2019 | De Notaristefani Carlo | Executive VP Global Operations | Sell | 5,041 | $17.88 | $90,107.88 | -29.4% | |
| Jan 2, 2019 | Fridriksdottir Hafrun47 | Executive VP, Global R&D | Sale+OE | 1,643 | $15.70 | $25,799.21 | -12.2% | |
| Nov 30, 2018 | Fridriksdottir Hafrun47 | Executive VP, Global R&D | Sale+OE | 933 | $21.76 | $20,304.04 | -9.6% |